Linvoseltamab
Product Specifications
CAS Number
2408319-25-3
Target
Integrin, TNF
Related Pathways
Apoptosis, Cytoskeletal Signaling
Bioactivity
Linvoseltamab, a bispecific antibody, targets both BCMA (TNFRSF17) and CD3 epsilon, demonstrating a favorable safety profile and promising efficacy in relapsed/refractory multiple myeloma (RRMM) [1][2].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog